YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3 -yl]-3-(3-methylphenyl)urea]: An irreversible cholecystokinin type-B receptor antagonist

Biochemical Pharmacology

Volumn 54, Issue 1, 1997, Pages 81-85

  Dunlop, John ^a   Brammer, Neil ^a   Evans, Non ^a,b   Ennis, Chris ^a  

^a PFIZER INC   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

CCK B receptor; Cholecystokinin; Irreversible antagonist; YM022

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; RECEPTOR SUBTYPE; TETRAGASTRIN;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE;

ANIMALS; BENZODIAZEPINES; BENZODIAZEPINONES; BINDING, COMPETITIVE; CALCIUM; CHO CELLS; CRICETINAE; HUMANS; PHENYLUREA COMPOUNDS; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; SIGNAL TRANSDUCTION; TETRAGASTRIN; TRANSFECTION;

EID: 0030836499     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00139-1     Document Type: Article

References (15)

1. Williams JA, Cholecystokinin: A hormone and neurotransmitter. Biomed Res 3: 107-115, 1982.
2. Hill DR, Campbell NJ, Shaw TM and Woodruff GN, Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. J Neurosci 7: 2967-2976, 1987.
3. Lotti VJ and Chang RSL, A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor ligand L-365,260. Eur J Pharmacol 162: 273-280, 1989.
4. Hughes J, Boden P, Costall B, Domeney A, Kelly E, Horwell DC, Hunter JC, Pinnock RD and Woodruff GN, Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA 87: 6728-6732, 1990.
5. Dourish CT, O'Neil MF, Coughlan J, Kitchener SJ, Hawley D and Iversen SD, The selective CCK-B receptor antagonist L-365260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur J Pharmacol 176: 35-44, 1990.
6. Bradwejn J, Koszycki D, Couetoux du Tertre A, van Megan H, den Boer J and Westenberg H, The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry 51: 486-493, 1994.
7. Miyake A, Mochizuki S and Kawashima H, Characterization of cloned human cholecystokinin-B receptor as a gastrin receptor. Biochem Pharmacol 47: 1339-1343, 1994.
8. Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S, Kobayashi A, Kamato T, Ito H, Yamano M, Katuyama Y, Satoh M, Ohta M and Honda K, Pharmacological profile of (R)-1-[2,3-dihydro-1-(2′-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo. J Pharmacol Exp Ther 269: 725-731, 1994.
9. 2+ mobilization. Eur J Pharmacol 269: 249-254, 1994.
10. Dunlop J, Brammer N and Ennis C, Pharmacological characterization of a Chinese hamster ovary cell line transfected with the human CCK-B receptor gene. Neuropeptides 30: 359-363, 1996.
11. 2+ mobilization in a pituitary cell line. Eur J Pharmacol 221: 99-105, 1992.
12. Witte DG, Nadzan AM, Martinez J, Rodriguez M and Lin CW, Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells. Peptides 13: 1227-1232, 1992.
13. 2+ concentration in the human JURKAT T lymphocyte cell line. Eur J Pharmacol 245: 241-246, 1993.
14. McConnell HM, Owicki JC, Parce JW, Miller DL, Baxter GT, Wada HG and Pitchford S, The cytosensor microphysiometer: Biological applications of silicon technology. Science 257: 1906-1912, 1992.
15. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.